Literature DB >> 12006322

Comparative study of different enzyme immunoassays for measurement of IgM and IgA rheumatoid factors.

S Bas1, T V Perneger, E Kunzle, T L Vischer.   

Abstract

OBJECTIVE: To compare the value of various IgM and IgA rheumatoid factor (RF) tests for the diagnosis of rheumatoid arthritis (RA).
METHODS: Firstly, the latex test, one global assay (for IgM, IgA, and IgG RF), six IgM, and four IgA RF assays were compared in a particularly challenging situation-that is, with 67 patients with RA, many of whom were latex negative, and 91 non-RA controls, many of whom were latex positive. More detailed evaluation followed with three IgM RF tests (two commercially available kits and one assay developed in our laboratory) and two IgA RF tests (one commercially available and one from our laboratory) in two more representative samples of rheumatological patients (146 RA and 75 non-RA controls).
RESULTS: Diagnostic performance differed considerably between the assays. For IgM RF detection the highest sensitivity (88%) was obtained with the Diamedix kit (specificity 67%) and for IgA RF with the Inova kit (sensitivity 65%, specificity 88%). Combining one IgM and one IgA RF test improved diagnostic performance when both tests were in agreement, but at the cost of yielding 15-27% of discrepant results which did not help in ruling RA in or out. Mean concentration values differed significantly among IgM RF tests, and in most cases concentrations were not correlated.
CONCLUSIONS: Available tests for IgM RF isotype vary in accuracy, and none is uniformly better than all the others. For IgA RF isotype, the Inova kit appears to be the best. Quantitative results cannot be compared across tests. Combination of one IgM and one IgA RF test may improve diagnostic accuracy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12006322      PMCID: PMC1754117          DOI: 10.1136/ard.61.6.505

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  28 in total

1.  Quantitation of rheumatoid factors (RF) of IgM, IgA and IgG isotypes by a simple and sensitive ELISA. Discrimination between false and true IgG-RF.

Authors:  G Kleveland; T Egeland; T Lea
Journal:  Scand J Rheumatol Suppl       Date:  1988

2.  Clinical value of ELISA assays for IgM and IgG rheumatoid factors.

Authors:  R Stone; J S Coppock; P T Dawes; P A Bacon; D L Scott
Journal:  J Clin Pathol       Date:  1987-01       Impact factor: 3.411

3.  A rapid enzyme immunoassay for the detection of IgM rheumatoid factor--a comparison of "sero-negative" and "sero-positive" rheumatoid patients.

Authors:  J G Larkin; R D Sturrock; W H Stimson
Journal:  J Clin Lab Immunol       Date:  1986-08

4.  A useful method for determining class-specific rheumatoid factors with computerized analyses of data.

Authors:  P L Gigase; C H Bridts; L S De Clerck; W J Stevens
Journal:  J Immunol Methods       Date:  1988-02-24       Impact factor: 2.303

5.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

6.  Which antigen to use in the detection of rheumatoid factors? Comparison of patients with rheumatoid arthritis and subjects with 'false positive' rheumatoid factor reactions.

Authors:  T Tuomi
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

7.  The latex test revisited. Rheumatoid factor testing in 8,287 rheumatic disease patients.

Authors:  F Wolfe; M A Cathey; F K Roberts
Journal:  Arthritis Rheum       Date:  1991-08

8.  Measuring rheumatoid factor in nonrheumatoid subjects: immunoturbidimetric assay, latex slide test, and enzyme-linked immunosorbent assay compared.

Authors:  K Ailus; L Melamies; T Tuomi; T Palosuo; K Aho
Journal:  Clin Chem       Date:  1991-10       Impact factor: 8.327

9.  Relationship of serum IgG rheumatoid factor to IgM rheumatoid factor and disease activity in rheumatoid arthritis.

Authors:  D L Robbins; D W Feigal; J C Leek
Journal:  J Rheumatol       Date:  1986-04       Impact factor: 4.666

10.  Rheumatoid factor and immune networks.

Authors:  D A Carson; P P Chen; R I Fox; T J Kipps; F Jirik; R D Goldfien; G Silverman; V Radoux; S Fong
Journal:  Annu Rev Immunol       Date:  1987       Impact factor: 28.527

View more
  11 in total

Review 1.  Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis.

Authors:  Rohit Aggarwal; Katherine Liao; Raj Nair; Sarah Ringold; Karen H Costenbader
Journal:  Arthritis Rheum       Date:  2009-11-15

2.  Predictive value of anti-citrullinated peptide antibodies: a real life experience.

Authors:  Abdulla Watad; Nancy Agmon-Levin; Boris Gilburd; Merav Lidar; Howard Amital; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

Review 3.  Association of susceptible genetic markers and autoantibodies in rheumatoid arthritis.

Authors:  Vasanth Konda Mohan; Nalini Ganesan; Rajasekhar Gopalakrishnan
Journal:  J Genet       Date:  2014-08       Impact factor: 1.166

4.  Rheumatoid factor measurement--continuing problems 70 years after discovery.

Authors:  Rohan Ameratunga; Samarina Musaad; Claudia Sugrue; Campbell Kyle
Journal:  Clin Rheumatol       Date:  2011-04-01       Impact factor: 2.980

5.  Is measurement of IgM and IgA rheumatoid factors (RF) in juvenile rheumatoid arthritis clinically useful?

Authors:  Rosa A Ferreira; Carlos H M Silva; Deise A O Silva; Monica C Sopelete; Maria H B Kiss; Jose R Mineo; Virginia P L Ferriani
Journal:  Rheumatol Int       Date:  2006-09-29       Impact factor: 2.631

6.  High IgA rheumatoid factor levels are associated with poor clinical response to tumour necrosis factor alpha inhibitors in rheumatoid arthritis.

Authors:  Francesca Bobbio-Pallavicini; Roberto Caporali; Claudia Alpini; Stefano Avalle; Oscar M Epis; Catherine Klersy; Carlomaurizio Montecucco
Journal:  Ann Rheum Dis       Date:  2006-11-01       Impact factor: 19.103

7.  Diagnostic value of anti-cyclic citrullinated peptides and association with HLA-DRB1 shared epitope alleles in African rheumatoid arthritis patients.

Authors:  Madeleine Singwe-Ngandeu; Axel Finckh; Sylvette Bas; Jean-Marie Tiercy; Cem Gabay
Journal:  Arthritis Res Ther       Date:  2010-03-02       Impact factor: 5.156

8.  Clinical utility of the anti-CCP assay in patients with rheumatic diseases.

Authors:  D M Lee; P H Schur
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

9.  A comparison of performance of anti-cyclic citrullinated peptide 2 and citrullinated protein antibodies in the diagnosis of rheumatoid arthritis in Iranian patients.

Authors:  Elham Aflaky; Saeedeh Shenavandeh; Mohammad Javad Ashraf
Journal:  Rheumatol Int       Date:  2009-08-12       Impact factor: 2.631

10.  Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis.

Authors:  Hassan El-Banna; Asif Jiman-Fatani
Journal:  BMC Musculoskelet Disord       Date:  2014-11-19       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.